ID   LIMK2_HUMAN             Reviewed;         638 AA.
AC   P53671; A8K6H5; Q7KZ80; Q7L3H5; Q96E10; Q99464; Q9UFU0;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   10-MAY-2017, entry version 178.
DE   RecName: Full=LIM domain kinase 2;
DE            Short=LIMK-2;
DE            EC=2.7.11.1;
GN   Name=LIMK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LIMK2A).
RC   TISSUE=Hepatoma;
RX   PubMed=8537403; DOI=10.1074/jbc.270.52.31321;
RA   Okano I., Hiraoka J., Otera H., Nunoue K., Ohashi K., Iwashita S.,
RA   Hirai M., Mizuno K.;
RT   "Identification and characterization of a novel family of
RT   serine/threonine kinases containing two N-terminal LIM motifs.";
RL   J. Biol. Chem. 270:31321-31330(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS LIMK2A AND LIMK2B), SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Lung;
RX   PubMed=8954941; DOI=10.1006/bbrc.1996.1847;
RA   Osada H., Hasada K., Inazawa J., Uchida K., Ueda R., Takahashi T.,
RA   Takahashi T.;
RT   "Subcellular localization and protein interaction of the human LIMK2
RT   gene expressing alternative transcripts with tissue-specific
RT   regulation.";
RL   Biochem. Biophys. Res. Commun. 229:582-589(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LIMK2B).
RC   TISSUE=Uterus;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LIMK2A).
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LIMK2A).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   INTERACTION WITH LKAP.
RA   Miyamoto K., Nakamura T., Shirakawa K., Matsumoto K.;
RT   "Molecular cloning and characterization of novel large protein,
RT   limkain b1, which associates with the LIM-kinase 2.";
RL   Submitted (MAR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   FUNCTION, AND INTERACTION WITH ROCK1.
RX   PubMed=10436159; DOI=10.1126/science.285.5429.895;
RA   Maekawa M., Ishizaki T., Boku S., Watanabe N., Fujita A., Iwamatsu A.,
RA   Obinata T., Ohashi K., Mizuno K., Narumiya S.;
RT   "Signaling from Rho to the actin cytoskeleton through protein kinases
RT   ROCK and LIM-kinase.";
RL   Science 285:895-898(1999).
RN   [11]
RP   PHOSPHORYLATION AT THR-505, MUTAGENESIS OF THR-505, FUNCTION, AND
RP   INTERACTION WITH ROCK1.
RX   PubMed=11018042; DOI=10.1074/jbc.M007074200;
RA   Sumi T., Matsumoto K., Nakamura T.;
RT   "Specific activation of LIM kinase 2 via phosphorylation of threonine
RT   505 by ROCK, a Rho-dependent protein kinase.";
RL   J. Biol. Chem. 276:670-676(2001).
RN   [12]
RP   PHOSPHORYLATION AT THR-505 BY CDC42BP.
RX   PubMed=11340065; DOI=10.1074/jbc.C100196200;
RA   Sumi T., Matsumoto K., Shibuya A., Nakamura T.;
RT   "Activation of LIM kinases by myotonic dystrophy kinase-related Cdc42-
RT   binding kinase alpha.";
RL   J. Biol. Chem. 276:23092-23096(2001).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-210 AND SER-293, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-293 AND SER-298, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-298, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   STRUCTURE BY NMR OF 62-129.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structures of the second LIM domain of human LIM-kinase 2
RT   (LIMK2).";
RL   Submitted (NOV-2005) to the PDB data bank.
RN   [18]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-35; ASN-45; CYS-213; ARG-296 AND
RP   CYS-418.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Displays serine/threonine-specific phosphorylation of
CC       myelin basic protein and histone (MBP) in vitro.
CC       {ECO:0000269|PubMed:10436159, ECO:0000269|PubMed:11018042}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBUNIT: Binds ROCK1 and LKAP. Interacts with PARD3. Interacts
CC       with NISCH (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       P08238:HSP90AB1; NbExp=2; IntAct=EBI-1384350, EBI-352572;
CC   -!- SUBCELLULAR LOCATION: Isoform LIMK2a: Cytoplasm. Nucleus.
CC       Note=Isoform LIMK2a is distributed in the cytoplasm and the
CC       nucleus.
CC   -!- SUBCELLULAR LOCATION: Isoform LIMK2b: Cytoplasm. Nucleus.
CC       Note=Isoform LIMK2b occurs mainly in the cytoplasm and is scarcely
CC       translocated to the nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=LIMK2a;
CC         IsoId=P53671-1; Sequence=Displayed;
CC       Name=LIMK2b;
CC         IsoId=P53671-2; Sequence=VSP_012287;
CC       Name=3;
CC         IsoId=P53671-3; Sequence=VSP_012287, VSP_043332;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highest expression in the placenta; moderate
CC       level in liver, lung, kidney, and pancreas. LIMK2a is found to be
CC       more abundant then LIMK2b in liver, colon, stomach, and spleen,
CC       while in brain, kidney, and placenta LIMK2b is the dominant form.
CC       In adult lung, both LIMK2a and LIMK2b is nearly equally observed.
CC       {ECO:0000269|PubMed:8954941}.
CC   -!- PTM: Phosphorylated on serine and/or threonine residues by ROCK1.
CC       {ECO:0000269|PubMed:11018042, ECO:0000269|PubMed:11340065}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr
CC       protein kinase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB54055.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D45906; BAA08312.1; -; mRNA.
DR   EMBL; D85527; BAA12827.1; -; mRNA.
DR   EMBL; AL117466; CAB55941.1; -; mRNA.
DR   EMBL; CR456513; CAG30399.1; -; mRNA.
DR   EMBL; AK291640; BAF84329.1; -; mRNA.
DR   EMBL; AC002073; AAB54055.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AC002073; AAB54056.1; -; Genomic_DNA.
DR   EMBL; CH471095; EAW59954.1; -; Genomic_DNA.
DR   EMBL; CH471095; EAW59956.1; -; Genomic_DNA.
DR   EMBL; CH471095; EAW59958.1; -; Genomic_DNA.
DR   EMBL; BC013051; AAH13051.1; -; mRNA.
DR   CCDS; CCDS13891.1; -. [P53671-1]
DR   CCDS; CCDS13892.1; -. [P53671-2]
DR   CCDS; CCDS33637.1; -. [P53671-3]
DR   PIR; A59196; A59196.
DR   RefSeq; NP_001026971.1; NM_001031801.1. [P53671-3]
DR   RefSeq; NP_005560.1; NM_005569.3. [P53671-1]
DR   RefSeq; NP_057952.1; NM_016733.2. [P53671-2]
DR   UniGene; Hs.474596; -.
DR   PDB; 1X6A; NMR; -; A=62-129.
DR   PDB; 4TPT; X-ray; 2.60 A; A/B=330-632.
DR   PDBsum; 1X6A; -.
DR   PDBsum; 4TPT; -.
DR   ProteinModelPortal; P53671; -.
DR   SMR; P53671; -.
DR   BioGrid; 110173; 35.
DR   IntAct; P53671; 25.
DR   MINT; MINT-1190610; -.
DR   STRING; 9606.ENSP00000339916; -.
DR   BindingDB; P53671; -.
DR   ChEMBL; CHEMBL5932; -.
DR   GuidetoPHARMACOLOGY; 2055; -.
DR   iPTMnet; P53671; -.
DR   PhosphoSitePlus; P53671; -.
DR   BioMuta; LIMK2; -.
DR   DMDM; 1708824; -.
DR   EPD; P53671; -.
DR   MaxQB; P53671; -.
DR   PaxDb; P53671; -.
DR   PeptideAtlas; P53671; -.
DR   PRIDE; P53671; -.
DR   DNASU; 3985; -.
DR   Ensembl; ENST00000331728; ENSP00000332687; ENSG00000182541. [P53671-1]
DR   Ensembl; ENST00000333611; ENSP00000330470; ENSG00000182541. [P53671-2]
DR   Ensembl; ENST00000340552; ENSP00000339916; ENSG00000182541. [P53671-3]
DR   GeneID; 3985; -.
DR   KEGG; hsa:3985; -.
DR   UCSC; uc003akh.4; human. [P53671-1]
DR   CTD; 3985; -.
DR   DisGeNET; 3985; -.
DR   GeneCards; LIMK2; -.
DR   HGNC; HGNC:6614; LIMK2.
DR   HPA; CAB019313; -.
DR   HPA; HPA008183; -.
DR   HPA; HPA053882; -.
DR   MIM; 601988; gene.
DR   neXtProt; NX_P53671; -.
DR   OpenTargets; ENSG00000182541; -.
DR   PharmGKB; PA30387; -.
DR   eggNOG; ENOG410IEZ9; Eukaryota.
DR   eggNOG; COG0515; LUCA.
DR   GeneTree; ENSGT00530000063025; -.
DR   HOGENOM; HOG000013121; -.
DR   HOVERGEN; HBG052328; -.
DR   InParanoid; P53671; -.
DR   KO; K05744; -.
DR   OMA; PECLPRT; -.
DR   OrthoDB; EOG091G03ZL; -.
DR   PhylomeDB; P53671; -.
DR   TreeFam; TF318014; -.
DR   BRENDA; 2.7.10.2; 2681.
DR   Reactome; R-HSA-3928662; EPHB-mediated forward signaling.
DR   Reactome; R-HSA-416572; Sema4D induced cell migration and growth-cone collapse.
DR   Reactome; R-HSA-5627117; RHO GTPases Activate ROCKs.
DR   SIGNOR; P53671; -.
DR   ChiTaRS; LIMK2; human.
DR   EvolutionaryTrace; P53671; -.
DR   GeneWiki; LIMK2; -.
DR   GenomeRNAi; 3985; -.
DR   PRO; PR:P53671; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000182541; -.
DR   CleanEx; HS_LIMK2; -.
DR   ExpressionAtlas; P53671; baseline and differential.
DR   Genevisible; P53671; HS.
DR   GO; GO:0005801; C:cis-Golgi network; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; TAS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; TAS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:Ensembl.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; TAS:UniProtKB.
DR   GO; GO:0004871; F:signal transducer activity; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0016310; P:phosphorylation; TAS:UniProtKB.
DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR001781; Znf_LIM.
DR   Pfam; PF00412; LIM; 2.
DR   Pfam; PF00595; PDZ; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   SMART; SM00132; LIM; 2.
DR   SMART; SM00228; PDZ; 1.
DR   SUPFAM; SSF50156; SSF50156; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00478; LIM_DOMAIN_1; 2.
DR   PROSITE; PS50023; LIM_DOMAIN_2; 2.
DR   PROSITE; PS50106; PDZ; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Cytoplasm; Kinase; LIM domain; Metal-binding; Nucleotide-binding;
KW   Nucleus; Phosphoprotein; Polymorphism; Reference proteome; Repeat;
KW   Serine/threonine-protein kinase; Transferase; Zinc.
FT   CHAIN         1    638       LIM domain kinase 2.
FT                                /FTId=PRO_0000075809.
FT   DOMAIN       12     63       LIM zinc-binding 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   DOMAIN       72    124       LIM zinc-binding 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   DOMAIN      152    239       PDZ. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00143}.
FT   DOMAIN      331    608       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     337    345       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    451    451       {ECO:0000250}.
FT   BINDING     360    360       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     210    210       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   MOD_RES     293    293       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976}.
FT   MOD_RES     298    298       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     505    505       Phosphothreonine; by ROCK1 and CDC42BP.
FT                                {ECO:0000269|PubMed:11018042,
FT                                ECO:0000269|PubMed:11340065}.
FT   VAR_SEQ       1     37       MSALAGEDVWRCPGCGDHIAPSQIWYRTVNETWHGSC ->
FT                                MGSYLSVPAYFTSRDL (in isoform LIMK2b and
FT                                isoform 3). {ECO:0000303|PubMed:11230166,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:8954941}.
FT                                /FTId=VSP_012287.
FT   VAR_SEQ     592    638       PAFSKLEDSFEALSLYLGELGIPLPAELEELDHTVSMQYGL
FT                                TRDSPP -> APPGAAGEGPGCADDEGPVRRQGKVTIKYDP
FT                                KELRKHLNLEEWILEQLTRLYDCQEEEISELEIDVDELLDM
FT                                ESDDAWASRVKELLVDCYKPTEAFISGLLDKIRAMQKLSTP
FT                                QKK (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043332.
FT   VARIANT      35     35       G -> S (in dbSNP:rs5997917).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_034069.
FT   VARIANT      45     45       D -> N (in dbSNP:rs35923988).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042249.
FT   VARIANT     213    213       R -> C (in dbSNP:rs34930775).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042250.
FT   VARIANT     296    296       P -> R (in dbSNP:rs34875793).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042251.
FT   VARIANT     381    381       R -> H (in dbSNP:rs2229874).
FT                                /FTId=VAR_050149.
FT   VARIANT     418    418       R -> C (in dbSNP:rs35422808).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042252.
FT   MUTAGEN     505    505       T->E: Increases kinase activity.
FT                                {ECO:0000269|PubMed:11018042}.
FT   MUTAGEN     505    505       T->V: Abolishes cofilin phosphorylation
FT                                and enhancement of stress fiber
FT                                formation. {ECO:0000269|PubMed:11018042}.
FT   TURN         73     75       {ECO:0000244|PDB:1X6A}.
FT   TURN         99    101       {ECO:0000244|PDB:1X6A}.
FT   STRAND      111    113       {ECO:0000244|PDB:1X6A}.
FT   STRAND      115    117       {ECO:0000244|PDB:1X6A}.
FT   STRAND      119    121       {ECO:0000244|PDB:1X6A}.
FT   HELIX       122    129       {ECO:0000244|PDB:1X6A}.
FT   STRAND      331    338       {ECO:0000244|PDB:4TPT}.
FT   STRAND      340    342       {ECO:0000244|PDB:4TPT}.
FT   STRAND      344    350       {ECO:0000244|PDB:4TPT}.
FT   TURN        351    353       {ECO:0000244|PDB:4TPT}.
FT   STRAND      356    361       {ECO:0000244|PDB:4TPT}.
FT   HELIX       367    375       {ECO:0000244|PDB:4TPT}.
FT   HELIX       377    382       {ECO:0000244|PDB:4TPT}.
FT   STRAND      391    396       {ECO:0000244|PDB:4TPT}.
FT   STRAND      398    406       {ECO:0000244|PDB:4TPT}.
FT   STRAND      410    412       {ECO:0000244|PDB:4TPT}.
FT   HELIX       413    417       {ECO:0000244|PDB:4TPT}.
FT   HELIX       425    444       {ECO:0000244|PDB:4TPT}.
FT   TURN        454    456       {ECO:0000244|PDB:4TPT}.
FT   STRAND      457    460       {ECO:0000244|PDB:4TPT}.
FT   STRAND      465    467       {ECO:0000244|PDB:4TPT}.
FT   TURN        510    512       {ECO:0000244|PDB:4TPT}.
FT   HELIX       515    518       {ECO:0000244|PDB:4TPT}.
FT   HELIX       527    541       {ECO:0000244|PDB:4TPT}.
FT   TURN        547    549       {ECO:0000244|PDB:4TPT}.
FT   HELIX       560    567       {ECO:0000244|PDB:4TPT}.
FT   HELIX       576    583       {ECO:0000244|PDB:4TPT}.
FT   HELIX       588    590       {ECO:0000244|PDB:4TPT}.
FT   HELIX       594    608       {ECO:0000244|PDB:4TPT}.
FT   STRAND      609    611       {ECO:0000244|PDB:4TPT}.
FT   HELIX       617    630       {ECO:0000244|PDB:4TPT}.
SQ   SEQUENCE   638 AA;  72232 MW;  FB51813D99AFAC18 CRC64;
     MSALAGEDVW RCPGCGDHIA PSQIWYRTVN ETWHGSCFRC SECQDSLTNW YYEKDGKLYC
     PKDYWGKFGE FCHGCSLLMT GPFMVAGEFK YHPECFACMS CKVIIEDGDA YALVQHATLY
     CGKCHNEVVL APMFERLSTE SVQEQLPYSV TLISMPATTE GRRGFSVSVE SACSNYATTV
     QVKEVNRMHI SPNNRNAIHP GDRILEINGT PVRTLRVEEV EDAISQTSQT LQLLIEHDPV
     SQRLDQLRLE ARLAPHMQNA GHPHALSTLD TKENLEGTLR RRSLRRSNSI SKSPGPSSPK
     EPLLFSRDIS RSESLRCSSS YSQQIFRPCD LIHGEVLGKG FFGQAIKVTH KATGKVMVMK
     ELIRCDEETQ KTFLTEVKVM RSLDHPNVLK FIGVLYKDKK LNLLTEYIEG GTLKDFLRSM
     DPFPWQQKVR FAKGIASGMA YLHSMCIIHR DLNSHNCLIK LDKTVVVADF GLSRLIVEER
     KRAPMEKATT KKRTLRKNDR KKRYTVVGNP YWMAPEMLNG KSYDETVDIF SFGIVLCEII
     GQVYADPDCL PRTLDFGLNV KLFWEKFVPT DCPPAFFPLA AICCRLEPES RPAFSKLEDS
     FEALSLYLGE LGIPLPAELE ELDHTVSMQY GLTRDSPP
//
